These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6103793)

  • 1. Determination of a urinary epoxide metabolite of alclofenac in man.
    Slack JA; Ford-Hutchinson AW
    Drug Metab Dispos; 1980; 8(2):84-6. PubMed ID: 6103793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of human drug preparations in the horse. III. Orally administered alclofenac.
    Delbeke FT; Landuyt J; Debackere M
    J Vet Pharmacol Ther; 1994 Oct; 17(5):353-8. PubMed ID: 7853459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some biochemical and pharmacological properties of an epoxide metabolite of alclofenac.
    Slack JA; Ford-Hutchinson AW; Richold M; Choi BC
    Chem Biol Interact; 1981 Feb; 34(1):95-107. PubMed ID: 6109575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo studies on the potential mutagenicity of alclofenac, dihydroxyalclofenac and alclofenac epoxide.
    Mercier M; Poncelet F; de Meester C; McGregor DB; Willins MJ; Léonard A; Fabry L
    J Appl Toxicol; 1983 Oct; 3(5):230-6. PubMed ID: 6141199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of alclofenac in equine plasma and urine by high-performance liquid chromatography.
    Delbeke FT; Landuyt J; Debackere M
    J Chromatogr; 1993 Nov; 621(2):209-14. PubMed ID: 7905004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind one year clinical trial comparing alclofenac with gold in rheumatoid arthritis.
    Kadir N; Grayson MF; Campbell ED
    Ann Clin Res; 1983; 15(1):4-9. PubMed ID: 6134490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous pharmacokinetics of alclofenace in plasma and synovial fluid in patients with rheumatoid arthritis.
    Thomas GM; Rees P; Dippy JE; Maddock J
    Curr Med Res Opin; 1975; 3(5):264-7. PubMed ID: 241595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The destruction of cytochrome P-450 by alclofenac: possible involvement of an epoxide metabolite.
    Brown LM; Ford-Hutchinson AW
    Biochem Pharmacol; 1982 Jan; 31(2):195-9. PubMed ID: 6120697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of methyldopa in man after oral administration of the pivaloyloxyethyl ester.
    Vickers S; Duncan CA; Ramjit HG; Dobrinska MR; Dollery CT; Gomez HJ; Leidy HL; Vincek WC
    Drug Metab Dispos; 1984; 12(2):242-6. PubMed ID: 6144491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary excretion pattern of methaqualone metabolites in man.
    Ericsson O; Danielsson B
    Drug Metab Dispos; 1977; 5(6):497-502. PubMed ID: 21773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term study of indomethacin and alclofenac in treatment of rheumatoid arthritis.
    Aylward M; Parker RJ; Holly F; Maddock J; Davies DB
    Br Med J; 1975 Apr; 2(5961):7-9. PubMed ID: 236805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the activity of alclofenac and of acetylsalicylic acid in rheumatoid arthritis; a double blind study and cross permutation].
    Fostiropoulos G
    Therapie; 1974; 29(6):933-9. PubMed ID: 4618390
    [No Abstract]   [Full Text] [Related]  

  • 13. Double-blind comparison of alclofenac and aspirin in the treatment of rheumatoid arthritis. Part II: high dosage regime for assessment of analgesic and anti-inflammatory activity.
    Bedi SS
    Curr Med Res Opin; 1975; 3(5):309-20. PubMed ID: 241600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and urinary excretion of p-chlorophenoxyacetamide, a metabolite of iproclozide, in humans.
    De Sagher RM; De Leenheer AP; Cruyl AA; Claeys AE
    Drug Metab Dispos; 1975; 3(6):423-9. PubMed ID: 1217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and quantitation of 5-fluorouridine in rat urine after administration of 5-fluorouracil or 5-fluoro-2'-deoxyuridine.
    Gelijkens CF; Sandra P; Belpaire F; De Leenheer AP
    Drug Metab Dispos; 1980; 8(5):363-6. PubMed ID: 6107236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of rheumatoid arthritis with tolmetin: a comparison with alclofenac.
    Aylward M; Holly F; Maddock J; Wheeldon R
    Curr Med Res Opin; 1976-1977; 4(10):695-702. PubMed ID: 19205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of proxyphylline in man. Isolation and identification of metabolites in urine.
    Selvig K; Bjerve KS
    Drug Metab Dispos; 1980; 8(6):456-62. PubMed ID: 6109616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of valproic acid metabolites in human serum and urine using hexadeuterated valproic acid and gas chromatographic mass spectrometric analysis.
    Acheampong A; Abbott F; Burton R
    Biomed Mass Spectrom; 1983 Nov; 10(11):586-95. PubMed ID: 6419788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double blind trial to assess the value of alclofenac compared with phenylbutazone in the management of rheumatoid arthritis.
    Chamberlain MA; Wright V
    Ann Rheum Dis; 1975 Apr; 34(2):186-9. PubMed ID: 237493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for evaluation of urinary excretion parameters of alclofenac after I.M. administration of its water soluble lysine salt in man.
    Testa R; Latini R
    Eur J Drug Metab Pharmacokinet; 1979; 4(2):91-6. PubMed ID: 39764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.